YOD1 serves as a potential prognostic biomarker for pancreatic cancer

YOD1 serves as a potential prognostic biomarker for pancreatic cancer

Abstract Background Ubiquitination is a basic post-translational modification of intracellular proteins and can be reversed enzymatically by DUBs (deubiquitinating enzymes). More than 90 DUBs have been identified. Among them, the deubiquitinating enzyme YOD1, a member of the ovarian tumor domain pro...

Full description

Bibliographic Details
Main Authors: Zhishuo Zhang, Wenxia Zhao, Yiming Li, Yang Li, Hanzeng Cheng, Liyun Zheng, Xiaoyu Sun, Hao Liu, Rongguang Shao
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Cancer Cell International
Subjects:
YOD1
OTUD2
Pancreatic cancer
Prognosis
Enrichment analysis
Biomarker
Online Access:https://doi.org/10.1186/s12935-022-02616-9

Internet

https://doi.org/10.1186/s12935-022-02616-9

Similar Items